News Website

Endometriosis imaging study highlights 99mTc-maraciclatide as diagnostic and monitoring tool - Med-Tech Insights

Endometriosis imaging study highlights 99mTc-maraciclatide as diagnostic and monitoring tool Med-Tech Insights

Published: May 8, 2026, 10:57 a.m.

Read Full Article

Endometriosis study paves way for new diagnostics and treatments - FemTech World

Endometriosis study paves way for new diagnostics and treatments FemTech World

Published: May 6, 2026, 1:02 p.m.

Read Full Article

Endometriosis Imaging Study Published in The Lancet Obstetrics, Gynaecology & Women's Health Highlights 99mTc-maraciclatide as a Promising Diagnostic and Monitoring Tool - The AI Journal

Endometriosis Imaging Study Published in The Lancet Obstetrics, Gynaecology & Women's Health Highlights 99mTc-maraciclatide as a Promising Diagnostic and Monitoring Tool The AI Journal

Published: April 30, 2026, 5:07 p.m.

Read Full Article

Endometriosis Imaging Study Published in The Lancet Obstetrics, Gynaecology & Women's Health Highlights 99mTc-maraciclatide as a Promising Diagnostic and Monitoring Tool - Morningstar

Endometriosis Imaging Study Published in The Lancet Obstetrics, Gynaecology & Women's Health Highlights 99mTc-maraciclatide as a Promising Diagnostic and Monitoring Tool Morningstar

Published: April 30, 2026, 12:01 p.m.

Read Full Article

Endometriosis Imaging Study Published in The Lancet Obstetrics, Gynaecology & Women's Health Highlights 99mTc-maraciclatide as a Promising Diagnostic and Monitoring Tool - PR Newswire

Endometriosis Imaging Study Published in The Lancet Obstetrics, Gynaecology & Women's Health Highlights 99mTc-maraciclatide as a Promising Diagnostic and Monitoring Tool PR Newswire

Published: April 30, 2026, 12:01 p.m.

Read Full Article

Proteomics diagnostic tests shift from lab coats to commercial launch - SMH.com.au

Proteomics diagnostic tests shift from lab coats to commercial launch SMH.com.au

Published: April 28, 2026, 7:02 a.m.

Read Full Article

Proteomics diagnostic tests shift from lab coats to commercial launch - smh.com.au

Proteomics diagnostic tests shift from lab coats to commercial launch smh.com.au

Published: April 28, 2026, 7:02 a.m.

Read Full Article

Feinstein Institutes' ROSE study continues to advance critical endometriosis diagnostic test - SelectScience

Feinstein Institutes' ROSE study continues to advance critical endometriosis diagnostic test SelectScience

Published: April 20, 2026, 8:49 a.m.

Read Full Article

LRP1 as a potential diagnostic and immunomodulatory target in endometriosis: evidence from multi-omics and single-cell analyses - Frontiers

LRP1 as a potential diagnostic and immunomodulatory target in endometriosis: evidence from multi-omics and single-cell analyses Frontiers

Published: April 15, 2026, 10:36 a.m.

Read Full Article

The Diagnostic Data Gap: How AI is Rewiring Clinical Infrastructure in Women’s Healthcare - The AI Journal

The Diagnostic Data Gap: How AI is Rewiring Clinical Infrastructure in Women’s Healthcare The AI Journal

Published: April 14, 2026, 9:21 a.m.

Read Full Article

Latest Articles

Endometriosis imaging study highlights 99mTc-maraciclatide as diagnostic and monitoring tool - Med-Tech Insights

Endometriosis study paves way for new diagnostics and treatments - FemTech World

Endometriosis Imaging Study Published in The Lancet Obstetrics, Gynaecology & Women's Health Highlights 99mTc-maraciclatide as a Promising Diagnostic and Monitoring Tool - The AI Journal

Endometriosis Imaging Study Published in The Lancet Obstetrics, Gynaecology & Women's Health Highlights 99mTc-maraciclatide as a Promising Diagnostic and Monitoring Tool - Morningstar

Endometriosis Imaging Study Published in The Lancet Obstetrics, Gynaecology & Women's Health Highlights 99mTc-maraciclatide as a Promising Diagnostic and Monitoring Tool - PR Newswire

Proteomics diagnostic tests shift from lab coats to commercial launch - SMH.com.au

Proteomics diagnostic tests shift from lab coats to commercial launch - smh.com.au

Feinstein Institutes' ROSE study continues to advance critical endometriosis diagnostic test - SelectScience

LRP1 as a potential diagnostic and immunomodulatory target in endometriosis: evidence from multi-omics and single-cell analyses - Frontiers

The Diagnostic Data Gap: How AI is Rewiring Clinical Infrastructure in Women’s Healthcare - The AI Journal

Subscribe to Our Newsletter